AU4399197A - Hepatitis c virus epitope - Google Patents
Hepatitis c virus epitopeInfo
- Publication number
- AU4399197A AU4399197A AU43991/97A AU4399197A AU4399197A AU 4399197 A AU4399197 A AU 4399197A AU 43991/97 A AU43991/97 A AU 43991/97A AU 4399197 A AU4399197 A AU 4399197A AU 4399197 A AU4399197 A AU 4399197A
- Authority
- AU
- Australia
- Prior art keywords
- hepatitis
- virus epitope
- epitope
- virus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 241000711549 Hepacivirus C Species 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
- C07K16/109—Hepatitis C virus; Hepatitis G virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
- C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
- C07K16/4216—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-viral Ig
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
- G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
- C12N2770/36122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/18—Togaviridae; Flaviviridae
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Communicable Diseases (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP29335996 | 1996-10-14 | ||
JP8-293359 | 1996-10-14 | ||
JP06544897A JP2002171972A (en) | 1996-10-14 | 1997-03-03 | Hepatitis kanen virus epitope |
JP9-65448 | 1997-03-03 | ||
PCT/JP1997/003551 WO1998016647A1 (en) | 1996-10-14 | 1997-10-03 | Hepatitis c virus epitope |
Publications (1)
Publication Number | Publication Date |
---|---|
AU4399197A true AU4399197A (en) | 1998-05-11 |
Family
ID=26406591
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU43991/97A Abandoned AU4399197A (en) | 1996-10-14 | 1997-10-03 | Hepatitis c virus epitope |
Country Status (3)
Country | Link |
---|---|
JP (1) | JP2002171972A (en) |
AU (1) | AU4399197A (en) |
WO (1) | WO1998016647A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000026673A1 (en) * | 1998-11-03 | 2000-05-11 | Abbott Laboratories | Methods of detecting chronic infection caused by hcv |
US20030166528A1 (en) * | 2000-10-11 | 2003-09-04 | Jong-Jye Lin | Antifungal compound |
AU2002243259B2 (en) | 2000-12-01 | 2008-02-07 | The Government Of The United States Of America, As Represented By The Secretary Department Of Health And Human Services | Monoclonal antibodies specific for the E2 glycoprotein of hepatitis C virus and their use in the diagnosis, treatment, and prevention of hepatitis C |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993006247A1 (en) * | 1991-09-16 | 1993-04-01 | Abbott Laboratories | Hepatitis c assay |
EP0589004B2 (en) * | 1992-03-06 | 2004-05-06 | N.V. Innogenetics S.A. | Process for the determination of peptides corresponding to immunologically important epitopes of hcv |
WO1994014974A1 (en) * | 1992-12-29 | 1994-07-07 | Akzo Nobel N.V. | Monoclonal antibodies and anti-idiotypic antibodies to hepatitis c virus |
DE19504302A1 (en) * | 1995-02-09 | 1996-08-14 | Boehringer Mannheim Gmbh | Method for serological typing using type-specific antigens |
US6110465A (en) * | 1995-06-07 | 2000-08-29 | The United States Of America As Represented By The Department Of Health And Human Services | Nucleotide and deduced amino acid sequences of hypervariable region 1 of the envelope 2 gene of isolates of hepatitis C virus and the use of reagents derived from these hypervariable sequences in diagnostic methods and vaccines |
-
1997
- 1997-03-03 JP JP06544897A patent/JP2002171972A/en not_active Withdrawn
- 1997-10-03 WO PCT/JP1997/003551 patent/WO1998016647A1/en active Application Filing
- 1997-10-03 AU AU43991/97A patent/AU4399197A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1998016647A1 (en) | 1998-04-23 |
JP2002171972A (en) | 2002-06-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2064297A (en) | Hepatitis c virus ribozymes | |
AU2550995A (en) | Hepatitis c virus asialoglycoproteins | |
AU6304996A (en) | Vaccines against hepatitis c | |
AU4878096A (en) | Hepatitis b vaccine | |
AU3434393A (en) | Targeted virus | |
AU2272997A (en) | Software anti-virus facility | |
GB9415369D0 (en) | Mutant virus | |
AUPM411994A0 (en) | Epitopes | |
AU3714499A (en) | Hepatitis c virus mimotopes | |
AU2645297A (en) | Hepatitis b monoclonal antibodies | |
AUPO026596A0 (en) | Viral peptide | |
AU5679394A (en) | Hepatitis b virus vaccines | |
AU4554899A (en) | Novel hepatitis c virus peptides and uses thereof | |
AU1773099A (en) | Materials for virus capture | |
AU3552797A (en) | Vaccine preparations | |
AU4399197A (en) | Hepatitis c virus epitope | |
AU688259B2 (en) | Hepatitis C virus peptides | |
AU1991095A (en) | Activating virus | |
AU7336296A (en) | Human hepatitis b virus dna | |
AU7334498A (en) | Hepatitis b virus mutations | |
AU2679797A (en) | Improved utilization of virus | |
AU3072395A (en) | Polyepitope vaccines | |
AU1950797A (en) | Vacuum attachment | |
AU4156096A (en) | Non-infective vaccines | |
AU1205497A (en) | Vaccine component |